References
-
1
American Diabetes Association .
Tests of glycemia in diabetes.
Diabetes Care.
2004;
27
S91-S93
-
2
Coster S, Gulliford M C, Seed P T, Powrie J K, Swaminathan R.
Self-monitoring in type 2 diabetes mellitus: a meta-analysis.
Diabet Med.
2000;
17
755-761
-
3
Davidson M B.
Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money.
Diabetes Care.
2005;
28
1531-1533
-
16
Franciosi M, Pellegrini F, de Berardis G. et al .
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control.
Diabet Med.
2005;
22
900-906
-
4
Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R.
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
BMJ.
2000;
320
1373-1378
-
5
Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet C, Vialettes B, Charbonnel B, Group A SIA.
Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) Study.
Diabetes Metab.
2003;
29
587-594
-
6
Herman W H, Eastman R C.
The effects of treatment on the direct costs of diabetes.
Diabetes Care.
1998;
21
C19-C24
-
7
Ipp E, Aquino R L, Christenson P.
Point: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach.
Diabetes Care.
2005;
28
1528-1530
-
8
Karter A J, Ackerson L M, Darbinian J A. et al .
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry.
Am J Med.
2001;
111
1-9
-
9
Martin S, Schneider B, Heinemann L, Lodwig V, Kurth H J, Kolb H, Scherbaum W A.
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.
Diabetologia.
2006;
49
271-278
-
10
Murata G H, Shah J H, Hoffman R M, Wendel C S, Adam K D, Solvas P A, Bokhari S U, Duckworth W C. Diabetes Outcomes in Veterans Study (DOVES) .
Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Diabetes Care.
2003;
26
1759-1763
-
11
O'Brien J A, Patrick A R, Caro J.
Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.
Clin Ther.
2003;
25
1017-1038
-
12
Schwedes U, Siebolds M, Mertes G. SMBG Study Group .
Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients.
Diabetes Care.
2002;
25
1928-1932
-
13
The Diabetes Control and Complications Trial Research Group .
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med.
1993;
329
977-986
-
14
UKPDS Group .
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Lancet.
1998;
352
837-853
-
15
Welschen L M, Bloemendal E, Nijpels G, Dekker J M, Heine R J, Stalman W A, Bouter L M.
Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin.
Cochrane Database Syst Rev.
2005;
CD005060
Prof. Dr. med. W. Kern
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Medizinische Klinik I
Ratzeburger Allee 160
23538 Lübeck
Germany
Phone: + 49 451 500 22 46
Fax: + 49 451 500 29 38
Email: kern@kfg.uni-luebeck.de